688363 Stock Overview
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Bloomage BioTechnology Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥63.39 |
| 52 Week High | CN¥99.49 |
| 52 Week Low | CN¥50.22 |
| Beta | 0.74 |
| 1 Month Change | 16.06% |
| 3 Month Change | n/a |
| 1 Year Change | -31.66% |
| 3 Year Change | -71.08% |
| 5 Year Change | n/a |
| Change since IPO | -25.51% |
Recent News & Updates
Weak Statutory Earnings May Not Tell The Whole Story For Bloomage BioTechnology (SHSE:688363)
May 06
Getting In Cheap On Bloomage BioTechnology Corporation Limited (SHSE:688363) Might Be Difficult
May 01Shareholder Returns
| 688363 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 1.7% | -2.8% | 0.03% |
| 1Y | -31.7% | -17.5% | -10.2% |
Return vs Industry: 688363 underperformed the CN Biotechs industry which returned -17.5% over the past year.
Return vs Market: 688363 underperformed the CN Market which returned -10.2% over the past year.
Price Volatility
| 688363 volatility | |
|---|---|
| 688363 Average Weekly Movement | 4.8% |
| Biotechs Industry Average Movement | 6.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in CN Market | 10.7% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 688363 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688363's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 4,655 | Yan Zhao | www.bloomagebioactive.com |
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names.
Bloomage BioTechnology Corporation Limited Fundamentals Summary
| 688363 fundamental statistics | |
|---|---|
| Market cap | CN¥30.34b |
| Earnings (TTM) | CN¥635.44m |
| Revenue (TTM) | CN¥6.13b |
47.7x
P/E Ratio4.9x
P/S RatioIs 688363 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688363 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.13b |
| Cost of Revenue | CN¥1.65b |
| Gross Profit | CN¥4.48b |
| Other Expenses | CN¥3.85b |
| Earnings | CN¥635.44m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.33 |
| Gross Margin | 73.14% |
| Net Profit Margin | 10.36% |
| Debt/Equity Ratio | 0.6% |
How did 688363 perform over the long term?
See historical performance and comparison